“Costi Ed Effetti Di Risperidone Long Acting (RLA) Rispetto Ad Antipsicotici Atipici Nel Trattamento Dei Soggetti Schizofrenici in Italia”. Farmeconomia. Health economics and therapeutic pathways 5, no. 1 (March 15, 2004): 5–11. Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/782.